1 - 25 of 256 results for author:"Hashimoto Y." in Literature citations
Results Customize
› Repeat search in UniProtKB (10,525)
| Crystal structure of aldoxime dehydratase and its catalytic mechanism involved in carbon-nitrogen triple-bond synthesis. Nomura J., Hashimoto H., Ohta T., Hashimoto Y., Wada K., Naruta Y., Oinuma K., Kobayashi M. Proc. Natl. Acad. Sci. U.S.A. 110:2810-2815(2013) · UniProtKB (1) |
| Leukocyte cell-derived chemotaxin 2 is a zinc-binding protein. Okumura A., Suzuki T., Miyatake H., Okabe T., Hashimoto Y., Miyakawa T., Zheng H., Unoki-Kubota H., Ohno H., Dohmae N. et al. FEBS Lett. 587:404-409(2013) · Mapped (1) |
| Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis. Tazawa H., Yano S., Yoshida R., Yamasaki Y., Sasaki T., Hashimoto Y., Kuroda S., Ouchi M., Onishi T., Uno F. et al. Int. J. Cancer 131:2939-2950(2012) · Mapped (21) |
| Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells. Masuko K., Okazaki S., Satoh M., Tanaka G., Ikeda T., Torii R., Ueda E., Nakano T., Danbayashi M., Tsuruoka T. et al. PLoS ONE 7:e29728-e29728(2012) · Mapped (6) |
| A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression. Yamasaki Y., Tazawa H., Hashimoto Y., Kojima T., Kuroda S., Yano S., Yoshida R., Uno F., Mizuguchi H., Ohtsuru A. et al. Eur. J. Cancer 48:2282-2291(2012) · Mapped (33) |
| MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid beta precursor protein and presenilins. Tachi N., Hashimoto Y., Matsuoka M. Biochem. J. 442:413-422(2012) · Mapped (25) |
| Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Ichii O., Otsuka S., Sasaki N., Namiki Y., Hashimoto Y., Kon Y. Kidney Int. 81:280-292(2012) · Mapped (2) |
| A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans. Tsuboi S., Sutoh M., Hatakeyama S., Hiraoka N., Habuchi T., Horikawa Y., Hashimoto Y., Yoneyama T., Mori K., Koie T. et al. EMBO J. 30:3173-3185(2011) · Mapped (54) |
| The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody. Saito Y., Hashimoto Y., Kuroda J., Yasunaga M., Koga Y., Takahashi A., Matsumura Y. Eur. J. Cancer 47:2230-2239(2011) · Mapped (5) |
| Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Hassaninasab A., Hashimoto Y., Tomita-Yokotani K., Kobayashi M. Proc. Natl. Acad. Sci. U.S.A. 108:6615-6620(2011) · UniProtKB (2) |
| A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH. Futakawa S., Nara K., Miyajima M., Kuno A., Ito H., Kaji H., Shirotani K., Honda T., Tohyama Y., Hoshi K. et al. Neurobiol. Aging 33:1807-1815(2012) · Mapped (9) |
| Interaction of Hand2 and E2a is important for transcription of Phox2b in sympathetic nervous system neuron differentiation. Hashimoto Y., Tsutsumi M., Myojin R., Maruta K., Onoda F., Tashiro F., Ohtsu M., Murakami Y. Biochem. Biophys. Res. Commun. 408:38-44(2011) · Mapped (12) |
| Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein. Okuhira K., Ohoka N., Sai K., Nishimaki-Mogami T., Itoh Y., Ishikawa M., Hashimoto Y., Naito M. FEBS Lett. 585:1147-1152(2011) · Mapped (3) |
| VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin. Rossini L., Hashimoto Y., Suzuki H., Kurita M., Gianfriddo M., Scali C., Roncarati R., Franceschini D., Pollio G., Trabalzini L. et al. FASEB J. 25:1983-2000(2011) · Mapped (1) |
| Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy. Ohkawa M., Ohno Y., Masuko K., Takeuchi A., Suda K., Kubo A., Kawahara R., Okazaki S., Tanaka T., Saya H. et al. Biochem. Biophys. Res. Commun. 406:649-655(2011) · Mapped (4) |
| Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis. Kimura J., Ichii O., Otsuka S., Kanazawa T., Namiki Y., Hashimoto Y., Kon Y. PLoS ONE 6:e16472-e16472(2011) · Mapped (2) |
| MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. Otsubo T., Akiyama Y., Hashimoto Y., Shimada S., Goto K., Yuasa Y. PLoS ONE 6:e16617-e16617(2011) · Mapped (1) |
| MiR-9 downregulates CDX2 expression in gastric cancer cells. Rotkrua P., Akiyama Y., Hashimoto Y., Otsubo T., Yuasa Y. Int. J. Cancer 129:2611-2620(2011) · Mapped (1) |
| Hepatocyte nuclear factor 4 alpha is associated with mesenchymal-epithelial transition in developing kidneys of C57BL/6 mice. Kanazawa T., Ichii O., Otsuka S., Namiki Y., Hashimoto Y., Kon Y. J. Vet. Med. Sci. 73:601-607(2011) · Mapped (37) |
| CFTR-deficiency renders mice highly susceptible to cutaneous symptoms during mite infestation. Hashimoto Y., Shuto T., Mizunoe S., Tomita A., Koga T., Sato T., Takeya M., Suico M.A., Niibori A., Sugahara T. et al. Lab. Invest. 91:509-518(2011) · Mapped (52) |
| Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARgamma-selective agonists: discovery of reversed stereochemistry-activity relationship. Ohashi M., Oyama T., Nakagome I., Satoh M., Nishio Y., Nobusada H., Hirono S., Morikawa K., Hashimoto Y., Miyachi H. J. Med. Chem. 54:331-341(2011) · Mapped (1) |
| Genome sequence of Kitasatospora setae NBRC 14216T: an evolutionary snapshot of the family Streptomycetaceae. Ichikawa N., Oguchi A., Ikeda H., Ishikawa J., Kitani S., Watanabe Y., Nakamura S., Katano Y., Kishi E., Sasagawa M. et al. DNA Res. 17:393-406(2010) · UniProtKB (7,443) |
| Relationship between thymidylate synthase (TYMS) gene polymorphism and TYMS protein levels in patients with high-risk breast cancer. Fujishima M., Inui H., Hashimoto Y., Azumi T., Yamamoto N., Kato H., Hojo T., Yamato M., Matsunami N., Shiozaki H. et al. Anticancer Res. 30:4373-4379(2010) · Mapped (6) |
| Brain endothelial cells produce amyloid {beta} from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form. Kitazume S., Tachida Y., Kato M., Yamaguchi Y., Honda T., Hashimoto Y., Wada Y., Saito T., Iwata N., Saido T. et al. J. Biol. Chem. 285:40097-40103(2010) · Mapped (10) |
| Novel isonitrile hydratase involved in isonitrile metabolism. Sato H., Hashimoto Y., Fukatsu H., Kobayashi M. J. Biol. Chem. 285:34793-34802(2010) · UniProtKB (1) |